334 related articles for article (PubMed ID: 12477702)
1. Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): a retrospective study of 104 patients.
Guillamo JS; Créange A; Kalifa C; Grill J; Rodriguez D; Doz F; Barbarot S; Zerah M; Sanson M; Bastuji-Garin S; Wolkenstein P;
Brain; 2003 Jan; 126(Pt 1):152-60. PubMed ID: 12477702
[TBL] [Abstract][Full Text] [Related]
2. Posterior fossa tumors in children with neurofibromatosis type 1 (NF1).
Pascual-Castroviejo I; Pascual-Pascual SI; Viaño J; Carceller F; Gutierrez-Molina M; Morales C; Frutos-Martinez R
Childs Nerv Syst; 2010 Nov; 26(11):1599-603. PubMed ID: 20464401
[TBL] [Abstract][Full Text] [Related]
3. Neurofibromatosis type 1 and sporadic optic gliomas.
Singhal S; Birch JM; Kerr B; Lashford L; Evans DG
Arch Dis Child; 2002 Jul; 87(1):65-70. PubMed ID: 12089128
[TBL] [Abstract][Full Text] [Related]
4. Clinical presentation and prognostic indicators in 100 adults and children with neurofibromatosis 1 associated non-optic pathway brain gliomas.
Byrne S; Connor S; Lascelles K; Siddiqui A; Hargrave D; Ferner RE
J Neurooncol; 2017 Jul; 133(3):609-614. PubMed ID: 28593402
[TBL] [Abstract][Full Text] [Related]
5. Histologically benign, clinically aggressive: Progressive non-optic pathway pilocytic astrocytomas in adults with NF1.
Strowd RE; Rodriguez FJ; McLendon RE; Vredenburgh JJ; Chance AB; Jallo G; Olivi A; Ahn ES; Blakeley JO
Am J Med Genet A; 2016 Jun; 170(6):1455-61. PubMed ID: 26992069
[TBL] [Abstract][Full Text] [Related]
6. Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO).
Valentin T; Le Cesne A; Ray-Coquard I; Italiano A; Decanter G; Bompas E; Isambert N; Thariat J; Linassier C; Bertucci F; Bay JO; Bellesoeur A; Penel N; Le Guellec S; Filleron T; Chevreau C
Eur J Cancer; 2016 Mar; 56():77-84. PubMed ID: 26824706
[TBL] [Abstract][Full Text] [Related]
7. When do children with optic pathway tumours need treatment? An oncological perspective in 106 patients treated in a single centre.
Grill J; Laithier V; Rodriguez D; Raquin MA; Pierre-Kahn A; Kalifa C
Eur J Pediatr; 2000 Sep; 159(9):692-6. PubMed ID: 11014471
[TBL] [Abstract][Full Text] [Related]
8. Neurofibromatosis type 1 and high-grade tumors of the central nervous system.
Rosenfeld A; Listernick R; Charrow J; Goldman S
Childs Nerv Syst; 2010 May; 26(5):663-7. PubMed ID: 19937438
[TBL] [Abstract][Full Text] [Related]
9. Neurological complications of neurofibromatosis type 1 in adulthood.
Créange A; Zeller J; Rostaing-Rigattieri S; Brugières P; Degos JD; Revuz J; Wolkenstein P
Brain; 1999 Mar; 122 ( Pt 3)():473-81. PubMed ID: 10094256
[TBL] [Abstract][Full Text] [Related]
10. Optic pathway tumors in children: the effect of neurofibromatosis type 1 on clinical manifestations and natural history.
Listernick R; Darling C; Greenwald M; Strauss L; Charrow J
J Pediatr; 1995 Nov; 127(5):718-22. PubMed ID: 7472822
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of multidisciplinary management in pediatric low-grade gliomas.
Oh KS; Hung J; Robertson PL; Garton HJ; Muraszko KM; Sandler HM; Hamstra DA
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e481-8. PubMed ID: 21470783
[TBL] [Abstract][Full Text] [Related]
12. Neurofibromatosis type 1: brain stem tumours.
Bilaniuk LT; Molloy PT; Zimmerman RA; Phillips PC; Vaughan SN; Liu GT; Sutton LN; Needle M
Neuroradiology; 1997 Sep; 39(9):642-53. PubMed ID: 9335063
[TBL] [Abstract][Full Text] [Related]
13. Brainstem gliomas in adults: prognostic factors and classification.
Guillamo JS; Monjour A; Taillandier L; Devaux B; Varlet P; Haie-Meder C; Defer GL; Maison P; Mazeron JJ; Cornu P; Delattre JY;
Brain; 2001 Dec; 124(Pt 12):2528-39. PubMed ID: 11701605
[TBL] [Abstract][Full Text] [Related]
14. MRI and clinical differences between optic pathway tumours in children with and without neurofibromatosis.
Chateil JF; Soussotte C; Pédespan JM; Brun M; Le Manh C; Diard F
Br J Radiol; 2001 Jan; 74(877):24-31. PubMed ID: 11227773
[TBL] [Abstract][Full Text] [Related]
15. Suprasellar pilocytic astrocytoma: one national centre's experience.
Mandiwanza T; Kaliaperumal C; Khalil A; Sattar M; Crimmins D; Caird J
Childs Nerv Syst; 2014 Jul; 30(7):1243-8. PubMed ID: 24566674
[TBL] [Abstract][Full Text] [Related]
16. Multiple pilocytic astrocytomas of the cerebellum in a 17-year-old patient with neurofibromatosis type I.
Dunn IF; Agarwalla PK; Papanastassiou AM; Butler WE; Smith ER
Childs Nerv Syst; 2007 Oct; 23(10):1191-4. PubMed ID: 17457593
[TBL] [Abstract][Full Text] [Related]
17. Pediatric malignancies in neurofibromatosis type 1: A population-based cohort study.
Peltonen S; Kallionpää RA; Rantanen M; Uusitalo E; Lähteenmäki PM; Pöyhönen M; Pitkäniemi J; Peltonen J
Int J Cancer; 2019 Dec; 145(11):2926-2932. PubMed ID: 30724342
[TBL] [Abstract][Full Text] [Related]
18. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
19. Presentation of childhood CNS tumours: a systematic review and meta-analysis.
Wilne S; Collier J; Kennedy C; Koller K; Grundy R; Walker D
Lancet Oncol; 2007 Aug; 8(8):685-95. PubMed ID: 17644483
[TBL] [Abstract][Full Text] [Related]
20. Loss of neurofibromatosis 1 (NF1) gene expression in NF1-associated pilocytic astrocytomas.
Gutmann DH; Donahoe J; Brown T; James CD; Perry A
Neuropathol Appl Neurobiol; 2000 Aug; 26(4):361-7. PubMed ID: 10931370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
